SKIBSTED RUSSELL — SEC Form 4 filings
SEC reporting owner CIK 1308105. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-28.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-07-18 to 2026-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 7 filings — 16,705 shares, $41,674 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 3,277 shares @ $1.93 ($6,325) in Processa Pharmaceuticals, Inc., filed 2026-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | Chief Financial Officer | 12 | 7 legs · 16,705 sh · $41,674 | — | 5 |
Form 4 filings — SKIBSTED RUSSELL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 11,883 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 3,277 @ $1.93 | EDGAR |
| 2026-06-16 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,654 @ $2.22 | EDGAR |
| 2026-06-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,292 @ $2.57 | EDGAR |
| 2026-05-19 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 1,984 @ $2.97 | EDGAR |
| 2026-05-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,190 @ $2.69 | EDGAR |
| 2026-04-17 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 1,984 @ $2.97 | EDGAR |
| 2026-04-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,324 @ $2.54 | EDGAR |
| 2025-10-03 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 108,000 (derivative) @ $0 · Grant/award (A): 324,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Holdings only — no transactions reported | EDGAR |
| 2025-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 1,775,044 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1308105 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →